Brief: Hikal Announces US FDA Audit With Zero Observations
15/05/2023 05:49
May 15 (Reuters) - Hikal Ltd HIKA.NS :
* ANNOUNCES US FDA AUDIT WITH ZERO OBSERVATIONS
* INSPECTION AT CO'S PHARMACEUTICAL MANUFACTURING FACILITY
AT
PANOLI CONCLUDED WITH 'ZERO 483 OBSERVATIONS' FROM US FDA
Source text for Eikon: ID:nBSE3RNzxR
Further company coverage: HIKA.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Hikal
See all newsBrief: Hikal Begins Commercial Production At New Cgmp Panoli Facility For Personal Care
Brief: Hikal June-Quarter Consol Loss 74 Million Rupees
India's Hikal slips after quarterly profit slump
Brief: Hikal March-Quarter Consol Net Profit 144 Million Rupees
India's Hikal down after revenue reporting discrepancies flagged